St. Marianna University School of Medicine;Daiichi Sankyo Company, Limited
发明人:
Yamano, Yoshihisa,Ueda, Natsumi,Araki, Kazushi
申请号：
AU2018210099
公开号：
AU2018210099A1
申请日:
2018.01.18
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present invention provides a pharmaceutical composition which can be used for the treatment of HTLV-1-associated myelopathy and contains an inhibitor selected from the group consisting of an EZH1 inhibitor, an EZH2 inhibitor and an EZH1/2 double inhibitor as an active ingredient. The present invention provides a pharmaceutical composition which can be used for the treatment of HTLV-1-associated myelopathy and contains a 1,3-benzodioxole derivative or a pharmaceutically acceptable salt thereof.
